RELAY THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: To elect the two class II directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Alexis Borisy

RELAY THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alexis Borisy”): 80,716,409 for, 43,000,380 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected each of the following individuals to serve as class II directors for a three-year term ending at the Company's 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified, or until his or her earlier death, resignati…”
Support: 65% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 26,592,394 for, 10,036,673 withheld.

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

Description as filed by funds: To elect the two class II directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Mark Murcko, Ph.D.

RELAY THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mark Murcko, Ph.D.”): 79,505,170 for, 44,211,619 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected each of the following individuals to serve as class II directors for a three-year term ending at the Company's 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified, or until his or her earlier death, resignati…”
Support: 64% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 25,811,160 for, 10,817,907 withheld.

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

Description as filed by funds: To consider and act upon an advisory vote on the compensation of our named executive officers;

RELAY THERAPEUTICS INC.’s own tally for this item (“2. Non-binding advisory vote on executive compensation”): 69,745,321 for, 53,852,178 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers, with the votes cast as follows:”
Support: 56% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 56 managers: 13,286,528 for, 23,309,624 against, 32,915 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 141 managers: 59,768,966 for, 35,590,369 against, 1,031,265 withheld. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; and

RELAY THERAPEUTICS INC.’s own tally for this item (“3. Ratification of appointment of independent registered public accounting firm”): 142,184,207 for, 163,544 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with the votes cast as follows:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 36,596,054 for, 98 against, 32,915 abstained.

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.